... ongoing HIV transmission Furthermore it was estimated that 86% of new smear-positive TB in patients with HIV infection was directly attributable to HIV The advent ofhighlyactiveantiretroviraltherapy ... prevalence of TB in HIV infected patients after the introduction of HAART has demonstrated remarkable changes towards improving the management ofHIV patients 27 The greatest proportion ofHIVassociated ... problem of adherence among HIV patients and patients co-infected with TB /HIV (4)A cohort study ofHIV patients on HAART is highly recommended in order to assess the effect of HAART on development of...
... and immunologic response to highlyactiveantiretroviraltherapy Curr HIV/ AIDS Rep 2004, 1:74-81 Marconi et al AIDS Research and Therapy 2010, 7:14 http://www.aidsrestherapy.com/content/7/1/14 ... adherence and simplicity for HIV- infected patients on antiretroviral therapy: selfreport of the relative importance of multiple attributes ofhighlyactiveantiretroviraltherapy (HAART) regimens ... (A) First AIDS event (B) Mortality Marconi et al AIDS Research and Therapy 2010, 7:14 http://www.aidsrestherapy.com/content/7/1/14 Page of 10 Table 3: Predictors of Time to Development of Outcomes...
... DeHovitz JA, Delapenha R, Gange SJ: Effect of discontinuing antiretroviraltherapy on survival of women initiated on highlyactiveantiretroviraltherapyAIDS 2004, 18:1579-1584 Van Roon EN, Verzijl ... the reasons for discontinuation of the first activeantiretroviraltherapy (HAART) regimen in a cohort ofantiretroviral naïve patients AIDS 2000, 14:499-507 Mocroft A, Youle M, Moore A, Sabin ... discontinuation of antiretrovirals: results from a single treatment centre AIDS 2001, 15:185-194 Palella FJ, Chmiel JS, Moorman AC, Homberg SD: Durability and predictors of success ofhighlyactive antiretroviral...
... support HIV Infection in the Era ofHighlyActiveAntiretroviral Treatment and Some of Its Associated Complications early initiation ofantiretroviraltherapy and aggressive management of cardiovascular ... and management of cardiovascular risk factors must be integrated on the routine ofHIV care HIV Infection in the Era ofHighlyActiveAntiretroviral Treatment and Some of Its Associated Complications ... levels in HIV- infected persons on antiretroviral therapy, but only moderately (Aberg et al., 2005) 8 HIV Infection in the Era ofHighlyActiveAntiretroviral Treatment and Some of Its Associated...
... determinants of nonadherence and nonreadiness to highlyactiveantiretroviraltherapy among people living with HIV/ AIDS in Northwest Ethiopia: a cross sectional study AIDS Research and Therapy 2010 ... decisions not to take up antiretroviraltherapy in Australians infected with HIV Int J STD AIDS 2000, 113:61-70 Machtinger EL, Bangsberg DR: Adherence to HIVAntiretroviraltherapyHIV In sit 2006, 7:16-22 ... virological failure on highlyactiveantiretroviraltherapy in HIV- 1 patients: a prospective cohort study Swiss HIV Cohort Study Lancet 1999, 353:863-868 Paredes R, Mocroft A, Kirk O, Lazzarin...
... response to highlyactiveantiretroviraltherapy following treatment for prevention of mother to child transmission of HIV- 1: a study in Côte d’Ivoire Journal of the International AIDS Society ... Abrams EJ, Rouzioux C, Dabis F: Maternal 12-month response to antiretroviraltherapy following prevention of mother-to-child transmission ofHIV type 1, Ivory Coast, 2003-2006 Clin Infect Dis 2008, ... Fowler M, Mofenson LM, Mmiro F, Jackson JB: Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV- 1 vertical transmission (HIVNET 012) AIDS 2001,...
... modulation of cell surface markers occurs during the course ofHIV disease and following the initiation of HAART and these cell surface markers may indicate the outcome ofantiretroviraltherapy ... responder Log10 ofHIV RNA copies/ml in plasma, detected by quantitative reverse transcription-PCR, was plotted against time from the date of initiation oftherapy Values ofHIV RNA copies/ml ... microarray analysis ofHIV disease status as well as for classifying leukemia types [2,3] During the natural course ofHIV infection, the major determinant of the depletion of CD4+ T cells is...
... Newlands D: Costing universal access ofhighlyactiveantiretroviraltherapy in Benin AIDS Care 2008, 20(5):582-587 Duff et al Journal of the International AIDS Society 2010, 13:37 http://www.jiasociety.org/content/13/1/37 ... 2003 Uganda Ministry of Health: Policy guidelines for prevention of mother to child transmission ofHIV [Revised edition], Kampala 2006 Kilian A: HIV/ AIDS Control in Kabarole District Eschborn; ... all forms of assistance (defaulted HAART) HIV- related stigma Most patients acknowledged that HIV/ AIDS stigma was prevalent within their communities and that people living with HIV/ AIDS were discriminated...
... [12] In Ethiopia, antiretroviraltherapy (ART) has been made available to HIV/ AIDS patients since 2004 Although over 250,000 HIV/ AIDS patients require ART in the country, only 24% of the eligible ... (%) Site of TB (%) Huruy et al AIDS Research and Therapy 2010, 7:46 http://www.aidsrestherapy.com/content/7/1/46 Page of IRD was variable and ranged from 11 to 329 days with a mean ± SD of 96 ± ... MR, Lange JM, Miedema F, Reiss P: Immunopathology as a result ofhighlyactiveantiretroviraltherapy in HIV- 1-infected patients AIDS 1999, 13:177-184 Murdoch DM, Venter WD, Feldman C, Van Rie...
... 10 11 Abbreviations HAART- highlyactiveantiretroviraltherapy HIV- 1-Ag-ELISpot- HIV- 1-antigens-ELISpot assay HIV- 1-Ag-SCs- HIV- 1-antigens-secreting cells HIV- 1-SCs- HIV- 1-secretring cells 12 ... studies, we developed an HIV- 1-antigen-ELISpot assay (HIV- 1-Ag-ELISpot) for the enumeration of HIV- 1-antigen-secreting cells (HIV- 1-Ag-SCs) after in vitro polyclonal activation ofhighly purified resting ... HIV- 1 DNA in subjects followed since primary HIV- 1 infection who suppress plasma viral load after one year ofhighlyactiveantiretroviraltherapyAIDS 2001, 15(6):665-673 Bukrinsky MI, Stanwick...
... with HIV infection in the era ofhighlyactiveantiretroviraltherapy Chest 2004, 125:1800-1804 Palacios R, Hidalgo A, Reina C, de la Torre M, Marquez M, Santos J: Effect ofantiretroviraltherapy ... S, Wallace MR: Comparisons of causes of death and mortality rates among HIV- infected persons: analysis of the pre-, early, and late HAART (highly activeantiretroviral therapy) eras J Acquir Immune ... in the burden of co-morbidities or in the HIV load and CD4 cell count The increased number of ICU admissions of HIV- positive patients over time despite the stable incidence ofHIV infection in...
... Sirisanthana T, Sirisanthana V: Efficacy ofhighlyactiveantiretroviraltherapy in HIV- infected children participating in Thailand's National Access to Antiretroviral Program Clin Infect Dis 2005, ... response to highlyactiveantiretroviral therapies among HIV- 1-infected Kenyan children J Acquir Immune Defic Syndr 2007, 45:311-317 Guidelines to antiretroviraltherapy in Kenya Ministry of Health, ... Journal of the International AIDS Society 2009, 12:8 Introduction As highlyactiveantiretroviraltherapy (HAART) becomes increasingly available to African...
... interval; HAART: Highlyactiveantiretroviraltherapy (triple therapy) ; HIV: Human immunodeficiency virus; LBW: Low birth weight (less than 2.5 kg); MTCT: Mother to child transmission (of HIV) ; NNRTI: ... Increased risk of adverse pregnancy outcomes in HIV- infected women treated with highlyactiveantiretroviraltherapy in Europe Aids 2004, 18:2337-2339 Tuomala RE, Shapiro DE, Mofenson LM, Bryson ... interested in assessing the effects of drug regimen on LBW independent of the roleof infant HIV infection, we initially restricted multivariate analysis of LBW to HIVnegative infants and thereafter...
... al AIDS Research and Therapy 2010, 7:39 http://www.aidsrestherapy.com/content/7/1/39 fully adhere to their HighlyActiveAntiretroviralTherapy (HAART) regimens [8-11] Incomplete adherence to antiretroviral ... Determinants of adherence to highlyactiveantiretroviraltherapy (HAART) in Chinese HIV/ AIDS patients HIV Med 2003, 4(2):133-8 49 Davies MA, Boulle A, Fakir T, Nuttall J, Eley B: Adherence to antiretroviral ... et al: Predictors ofAntiretroviral Adherence AIDS Care 2004, 16:471-484 Tiyou et al AIDS Research and Therapy 2010, 7:39 http://www.aidsrestherapy.com/content/7/1/39 Page 10 of 10 48 Fong OW,...
... mobilisation of triglycerides stores to promote fatty acid oxidation [19] In line with our earlier report of a lack of effect on fasting NEFA levels [12], data here argue against a roleof aberrant ... 0.001 0.68 Page of Circulating levels of Pre-treatment metabolically active hormones (page number not for citation purposes) http://www.jnrbm.com/content/5/1/14 Table 1: Plasma levels of TNF alpha, ... CRP with metabolically active hormone levels It is important to place our findings in the context of other studies examining the impact of glucocorticoids on metabolically active hormones and cytokines...
... infection on length of stay and total cost of admission for patients with severe sepsis Outcome Impact of HIV/ AIDS P value Adjusted impact of HIV/ AIDS P value Length of stay (days) -0.8 0.0669 -0.9a 0.0516 ... without HIV/ AIDS is ≤ 0.0001 for all characteristics unless otherwise noted b0.0001 < p ≤ 0.0500 cNumber excludes HIV/ AIDS dp > 0.0500 Length of stay For patients with SS, those with HIV/ AIDS had ... but without HIV/ AIDS Thus, the purpose of this study was two-fold: to examine patterns of care and outcomes for patients with SS and HIV/ AIDS; and to assess differences in patterns of care and...
... of the active species [76] Further support in favour of the idea of the involvement of a high-valent iron-oxene in P450 catalysis came from experiments with metalloporphyrin models [5,6,77] Of ... intermediate [11] The sum of these ndings points at the involvement of more than one active oxidant in the diverse types of P450-catalyzed substrate processing [1215] The goal of the present perspective ... seems worth mentioning that the rate of cumene hydroperoxide-induced loss of CO-reactive CYP2B4 [85] could be demonstrated to be far below that of release of N-oxy product from the ternary complex...
... the performance of PA in the formation of semisynthetic b-lactam antibiotics The X-ray structure of the complex of PA with PAA shows that the acyl binding site of PA is made up of several hydrophobic ... Stereoview of the active site of penicillin acylase complexed with PAA [2] The residues that have been mutated in this study, aF146, bF24, bF57 and PAA, are shown in white Ó FEBS 2002 Roleof active- site ... relative rates of reaction of the acyl-enzyme with different deacylating nucleophiles, leading to changes in the Vs/Vh ratios In this paper, we report the effect of modification of the three active- site...
... P, Pellegrin JL, Neau D, Dabis F: Factors associated with the occurrence of AIDS- related non-Hodgkin lymphoma in the era ofhighlyactiveantiretroviral therapy: Aquitaine Cohort, France Clin Infect ... before the onset of NHL An important feature of our cohort was the finding of symptomatic NHL occurring in the setting of profound HIV viral load decline following initiation of HAART This phenomenon ... lymphoma incidence in the Swiss HIV Cohort Study before and after highlyactiveantiretroviraltherapyAIDS 2008, 22:301-306 Dal Maso L, Franceschi S: Epidemiology of non-Hodgkin lymphomas and other...